Cord Blood America, Inc., the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and families nationwide and internationally, recently released an update to investors on the company’s achievements during the first quarter of 2010.
Cord Blood America’s co-founder and chief executive officer, Matthew Schissler, reviewed first quarter results and progress in an interview with analyst Francis Gaskins. The entire interview is available at: www.gaskinsco.com/cbai-5-20-10.mp3.
Mr. Schissler noted in the interview that the company is on-track with its partnership with AXM Pharma to open the world’s largest stem cell storage and processing facility in China by January 2011. Additionally, management is continuing its due diligence on the acquisition of an Argentina stem cell company with affiliates throughout South America.
Mr. Schissler also stated that there was essentially no dilution of common stock in the first quarter and that the stock’s current price does not reflect the progress that the company continues to make in its expansion efforts.
For additional information, please visit www.corcell.com and www.cordblood-america.com.
Let us hear your thoughts below: